From MFN to IRA, Experts Warn of a System Under Pressure in Wide-Ranging Policy Webinar

As drug pricing initiatives move forward while coverage policies grow more uncertain, the complexity of the Trump administration’s health care agenda is coming into sharper focus. During a March 3, 2026, webinar hosted by The American Journal of Managed Care^® (AJMC^®) and Managed Healthcare Executive^® (MHE), a pair of health policy experts assessed where things stand on drug pricing, the Affordable Care Act (ACA) subsidies, and other key priorities shaping the administration’s approach to health care.¹ The hour-long conversation covered a wide range of issues and revealed few easy answers.